Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Use of ultra-sensitive whole genome circulating tumor DNA detection to predict early recurrence in high-risk localized RCC after nephrectomy: Preliminary real-world findings.

Among 22 people with high-risk localized renal cell carcinoma tested with Next Personal Dx after nephrectomy, 3 had ctDNA detected and 2 of those recurred, while none of 16 with persistent ctDNA negativity recurred during follow-up.

ASCO Genitourinary Cancers Symposium 2026